The potential of patient-derived organoids in precision medicine of biliary tract cancer
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved..
Chemotherapy resistance in biliary tract cancer (BTC) presents a major clinical hurdle. Ren et al.1 developed and characterized an extensive collection of BTC patient-derived organoid (PDO) models, enabling advanced investigation of chemotherapy response prediction.
| Errataetall: |
CommentOn: Cell Rep Med. 2023 Nov 21;4(11):101277. - PMID 37944531 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
Cell reports. Medicine - 4(2023), 11 vom: 21. Nov., Seite 101294 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yáñez-Bartolomé, Mariana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 24.11.2023 Date Revised 12.02.2024 published: Print CommentOn: Cell Rep Med. 2023 Nov 21;4(11):101277. - PMID 37944531 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.xcrm.2023.101294 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364839511 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364839511 | ||
| 003 | DE-627 | ||
| 005 | 20240213232626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.xcrm.2023.101294 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1290.xml |
| 035 | |a (DE-627)NLM364839511 | ||
| 035 | |a (NLM)37992681 | ||
| 035 | |a (PII)S2666-3791(23)00488-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yáñez-Bartolomé, Mariana |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The potential of patient-derived organoids in precision medicine of biliary tract cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.11.2023 | ||
| 500 | |a Date Revised 12.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Cell Rep Med. 2023 Nov 21;4(11):101277. - PMID 37944531 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Chemotherapy resistance in biliary tract cancer (BTC) presents a major clinical hurdle. Ren et al.1 developed and characterized an extensive collection of BTC patient-derived organoid (PDO) models, enabling advanced investigation of chemotherapy response prediction | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 700 | 1 | |a Macarulla, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Tian, Tian V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell reports. Medicine |d 2020 |g 4(2023), 11 vom: 21. Nov., Seite 101294 |w (DE-627)NLM310587662 |x 2666-3791 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2023 |g number:11 |g day:21 |g month:11 |g pages:101294 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.xcrm.2023.101294 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2023 |e 11 |b 21 |c 11 |h 101294 | ||